Acute Lymphoblastic Leukemia

How a teddy bear is helping in the battle against cancer

He may not be able to fly, or be as fast as the speed of light, but for children who have been diagnosed with cancer at Seattle Children's, the cuddly teddy bear who wears a mask and purple cape is still a super hero to them ...

Sep 28, 2016
popularity3 comments 0

New drug hope for babies with leukaemia

Telethon Kids Institute (TKI) researchers have discovered a new drug combination to help babies battle a rare, aggressive type of leukaemia with grim cure rates.

Oct 12, 2016
popularity0 comments 0

Controlling cell-fate decisions

Rafal Ciosk and his group at the FMI have identified an important link between the Notch signaling pathway and PRC2-mediated gene silencing. They showed that a fine balance between epigenetic silencing and signaling is crucial ...

Sep 23, 2016
popularity1 comments 0

Adding rituximab to chemo ups event-free survival in ALL

(HealthDay)—For young adults with acute lymphoblastic leukemia (ALL), adding rituximab to chemotherapy is associated with increased event-free survival, according to a study published in the Sept. 15 issue of the New England ...

Sep 20, 2016
popularity1 comments 0

Immunotherapy a hot topic in treating cancers

Last Friday was Rebecca Hertzog Burns' birthday. She turned 2. She says that's her age, though she's really 27. After a relapse in her fight with acute myelogenous leukemia, Burns received a stem cell transplant on Sept. ...

Sep 15, 2016
popularity4 comments 0

Acute lymphoblastic leukemia (ALL) is a form of leukemia, or cancer of the white blood cells characterized by excess lymphoblasts.

Malignant, immature white blood cells continuously multiply and are overproduced in the bone marrow. ALL causes damage and death by crowding out normal cells in the bone marrow, and by spreading (infiltrating) to other organs. ALL is most common in childhood with a peak incidence at 2–5 years of age, and another peak in old age. The overall cure rate in children is about 80%, and about 45%-60% of adults have long-term disease-free survival.

Acute refers to the relatively short time course of the disease (being fatal in as little as a few weeks if left untreated) to differentiate it from the very different disease of chronic lymphocytic leukemia, which has a potential time course of many years. It is interchangeably referred to as Lymphocytic or Lymphoblastic. This refers to the cells that are involved, which if they were normal would be referred to as lymphocytes but are seen in this disease in a relatively immature (also termed 'blast') state.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

New trials offer hope for TB treatment

Researchers at the University of St Andrews are one step closer to finding a shorter, more effective treatment for TB, according to a new paper published by The Lancet Infectious Diseases.

Lactate measurement improves treatment during labour

Labour dystocia, or the failure of the uterus to contract properly during labour, is a serious problem in obstetrics. A new study from Karolinska Institutet demonstrates a simple method that can make it easier for doctors ...